Table 1.
IMPACT outcome measures at defined timepoints
| Measure | Baseline | 12 months | 15 months |
|---|---|---|---|
| SF-36 (Physical and mental health components) |
X |
X |
X |
| Time line follow back |
X |
X |
X |
| Nicotine dependence questionnaire |
X |
X |
X |
| AUDIT |
X |
X |
X |
| DINE |
X |
X |
X |
| IPAQ |
X |
X |
X |
| Waist/hip circumference ratio |
X |
X |
X |
| BMI |
X |
X |
X |
| Blood pressure |
X |
X |
X |
| Fasting glucose |
X |
X |
X |
| Insulin resistance |
X |
X |
X |
| Long term blood glucose control (HbA1c) |
X |
X |
X |
| Lipids |
X |
X |
X |
| Uric acid |
X |
X |
X |
| High sensitivity C reactive protein |
X |
X |
X |
| Urine drug screen |
X |
X |
X |
| PANSS |
X |
X |
X |
| GAF |
X |
X |
X |
| MADRS |
X |
X |
X |
| OPCRIT |
X |
X |
X |
| LUNSERS |
X |
X |
X |
| Age at randomisation |
X |
X |
X |
| Gender |
X |
X |
X |
| Ethnicity |
X |
X |
X |
| Marital status |
X |
X |
X |
| Current medications |
X |
X |
X |
| Medical history |
X |
X |
X |
| Measures of compliance (1–7 scale) | X | X | X |
Variables measured at baseline, 12 months and 15 months follow-up.